ADMA Biologics (ADMA) Announces Proposed $50M Stock Offering at $1/sh
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/20/2026
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Loop Capital downgrades Apple, sees no recovery of cut iPhone shipments
- Wells Fargo says S&P 500 buy signal emerges as investors turn excessively bearish
- ByteDance, Alibaba and Tencent order $35 billion of Nvidia chips: Reuters
After-Hours Stock Movers 10/20: (CSX) (THC) (CNI) Higher; (ADMA) (LRCX) (AMAT) Lower (more...)
October 20, 2021 5:51 PM EDTAfter-Hours Stock Movers:
ADMA Biologics, Inc. (Nasdaq: ADMA) 6.3% LOWER; announced that it intends to offer shares of its common stock for sale in an underwritten public offering.
ADMA Biologics (ADMA) Announces Proposed Public Offering of Common Stock
October 20, 2021 4:02 PM EDTADMA Biologics, Inc. (Nasdaq: ADMA) (ADMA or the Company), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, today announced that it intends to offer shares of its common stock for sale in an underwritten public offering. The Company intends to grant the underwriters of... More



